tirzepatide generic Mounjaro availability, cost, and more New Breakthrough Obesity Drug

Thirty percent of patients had dose reductions because of treatment-related adverse events, and 2% of patients discontinued the drug because of adverse events

I did about three months of research before trying it myself

One of the first dedicated investigations aimed at uncovering modification sites in the topology of a representative DPP-8/9 inhibitor capable of imparting selectivity for DPP-8 over DPP-9 was conducted by Van Goethem et al

There are still many healthcare policy and payer issues/trends that need to be carefully monitored in order to help companies understand whether or not they can afford to build their GLP-1 business in the United States

Improper injection techniques with Semaglutide can lead to localized trauma, causing skin pain, discomfort, or bruising

Fremlin Dekyi, MD, to support clinical accuracy and patient-friendly education about BMI requirements for GLP-1 weight loss treatment